GRP
PVLA

Global Retirement Partners’s Palvella Therapeutics PVLA Stock Holding History

Global Retirement Partners’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74K Buy
+31
New +$3.76K ﹤0.01% 3709
2025
Q4 		$2.93K Buy
+28
New +$2.39K ﹤0.01% 3607

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Global Retirement Partners's PVLA Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 31 shares worth $4.74K. The stake represents ﹤0.01% of the portfolio and ranks #3709 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in PVLA as recently as Q4 2025.

Global Retirement Partners first reported a position in PVLA in Q4 2025 and has held it in 2 quarters since. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Global Retirement Partners held 31 shares of Palvella Therapeutics worth $4.74K as of Q2 2026.
  • Palvella Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Palvella Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3709 holding.
  • Global Retirement Partners first reported a position in Palvella Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.